Dopamine d2 Receptor Antikörper (AA 214-373)
Kurzübersicht für Dopamine d2 Receptor Antikörper (AA 214-373) (ABIN6139821)
Target
Alle Dopamine d2 Receptor (DRD2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    
- 
                                            
Bindungsspezifität
 - AA 214-373
 - 
                                            
Sequenz
 - IVLRRRRKRV NTKRSSRAFR AHLRAPLKGN CTHPEDMKLC TVIMKSNGSF PVNRRRVEAA RRAQELEMEM LSSTSPPERT RYSPIPPSHH QLTLPDPSHH GLHSTPDSPA KPEKNGHAKD HPKIAKIFEI QTMPNGKTRT SLKTMSRRKL SQQKEKKATQ
 - 
                                            
Kreuzreaktivität
 - Human, Maus, Ratte
 - 
                                            
Produktmerkmale
 - Polyclonal Antibodies
 - 
                                            
Aufreinigung
 - Affinity purification
 - 
                                            
Immunogen
 - Recombinant fusion protein containing a sequence corresponding to amino acids 214-373 of human DRD2 (NP_000786.1).
 - 
                                            
Isotyp
 - IgG
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Applikationshinweise
 - WB,1:500 - 1:1000
 - 
                                            
Beschränkungen
 - Nur für Forschungszwecke einsetzbar
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Liquid
 - 
                                            
Buffer
 - PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
 - 
                                            
Konservierungsmittel
 - Sodium azide
 - 
                                            
Vorsichtsmaßnahmen
 - This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
Lagerung
 - -20 °C
 - 
                                            
Informationen zur Lagerung
 - Store at -20°C. Avoid freeze / thaw cycles.
 
 - 
                                            
 - 
    
- Dopamine d2 Receptor (DRD2) (Dopamine Receptor D2 (DRD2))
 - 
                                            
Andere Bezeichnung
 - DRD2
 - 
                                            
Hintergrund
 - This gene encodes the D2 subtype of the dopamine receptor. This G-protein coupled receptor inhibits adenylyl cyclase activity. A missense mutation in this gene causes myoclonus dystonia, other mutations have been associated with schizophrenia. Alternative splicing of this gene results in two transcript variants encoding different isoforms. A third variant has been described, but it has not been determined whether this form is normal or due to aberrant splicing.,DRD2,D2DR,D2R,Signal Transduction,G protein signaling,G-Protein-Coupled Receptors(GPCR),Neuroscience,Cell Type Marker,Neurodegenerative Diseases,Dopamine Signaling in Parkinson's Disease,Neuron marker,Dendrite marker,DRD2
 - 
                                            
Molekulargewicht
 - 47 kDa/50 kDa
 - 
                                            
Gen-ID
 - 1813
 - 
                                            
UniProt
 - P14416
 - 
                                            
Pathways
 - Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, cAMP Metabolic Process, Inositol Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Feeding Behaviour, Negative Regulation of Transporter Activity, Regulation of long-term Neuronal Synaptic Plasticity
 
Target
 -